Company: TXG
Filing Date: 2025-04-14
Form Type: DEF 14A
Source: 0001770787-25-000018
Chunk: 72

Company: 10x Genomics, Inc.
Filing Date: 2025-04-14
Form: DEF 14A
Chunk 72
---
 months of his base salary in effect at the time of his termination, subject to his execution and non-revocation of a release of claims, if he is terminated by us without Cause (as defined in the Severance Policy) prior to August 21, 2025.

#### Dr. Hindson
Dr. Hindson co-founded our company in 2012 and has not been party to an offer letter with us since our inception. In fiscal year 2024, Dr. Hindson was entitled to an annual base salary of $441,000, which was increased to $500,000 annualized effective April 1, 2024, and he was eligible to earn an annual target bonus equal to 60% of his eligible base salary. Additionally, Dr. Hindson is eligible to participate in employee benefit plans that are generally available to other senior executives of our company located in the United States.

#### Mr. Whitaker
Mr. Whitaker signed an offer letter with us on June 12, 2017, under which he was entitled to an annual base salary of $300,000. In fiscal year 2024, Mr. Whitaker was entitled to an annual base salary of $438,900, which was increased to $500,000 annualized effective April 1, 2024, and he was eligible to earn an annual target bonus equal to 60% of his eligible base salary. In addition, Mr. Whitaker is eligible to participate in employee benefit plans that are generally available to other senior executives of our company located in the United States.

#### Mr. McAnear
Mr. McAnear, our former chief financial offer, signed an offer letter with us on August 17, 2018, under which he was entitled to an annual base salary of $310,000. In fiscal year 2024, Mr. McAnear was entitled to an annual base salary of $419,000, which was increased to $485,000 annualized effective April 1, 2024, and he was eligible to earn an annual target bonus equal to 60% of his eligible base salary. Additionally, Mr. McAnear was eligible to participate in employee benefit plans that are generally available to other senior executives of our company located in the United States. All of Mr. McAnear's unvested equity awards as of the termination date were canceled and he did not receive any other separation payments or benefits upon his separation from the company effective August 30, 202